ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $40,000 | +8.1% | 24,815 | +88.3% | 0.01% | +16.7% |
| Q2 2018 | $37,000 | -65.7% | 13,178 | -64.5% | 0.01% | -68.4% |
| Q4 2017 | $108,000 | -21.7% | 37,171 | +13.5% | 0.02% | -40.6% |
| Q1 2017 | $138,000 | -68.1% | 32,757 | -41.0% | 0.03% | -72.6% |
| Q2 2016 | $433,000 | +263.9% | 55,521 | +260.4% | 0.12% | +265.6% |
| Q1 2016 | $119,000 | – | 15,407 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |